Graefes Arch Clin Exp Ophthalmol
March 2020
Purpose: To analyse current off-label use of bevacizumab for wet age-related macular degeneration (AMD) in Europe.
Methods: The study was conducted as a combined survey and literature review. It included the 22 most populous countries in Europe.